Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright restated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Up 2.9 %

AEMD stock opened at $0.57 on Thursday. The business has a 50 day moving average price of $0.41 and a 200 day moving average price of $0.42. The stock has a market cap of $7.95 million, a price-to-earnings ratio of -0.20 and a beta of 1.79. Aethlon Medical has a fifty-two week low of $0.24 and a fifty-two week high of $2.35.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.